119 related articles for article (PubMed ID: 9667400)
1. Physical performance in long-term survivors of acute leukaemia in childhood.
Black P; Gutjahr P; Stopfkuchen H
Eur J Pediatr; 1998 Jun; 157(6):464-7. PubMed ID: 9667400
[TBL] [Abstract][Full Text] [Related]
2. Low-dose daunorubicin in induction treatment of childhood acute lymphoblastic leukemia: no long-term cardiac damage in a randomized study of the Dutch Childhood Leukemia Study Group.
Rammeloo LA; Postma A; Sobotka-Plojhar MA; Bink-Boelkens MT; Berg A; Veerman AJ; Kamps WA
Med Pediatr Oncol; 2000 Jul; 35(1):13-9. PubMed ID: 10881002
[TBL] [Abstract][Full Text] [Related]
3. Cardiac functions by myocardial performance index and QT dispersion in survivors of childhood lymphoblastic leukaemia.
Gulen H; Kazanci E; Mese T; Uzunkaya D; Erbay A; Tavli V; Vergin C
Minerva Pediatr; 2007 Apr; 59(2):107-13. PubMed ID: 17404560
[TBL] [Abstract][Full Text] [Related]
4. Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer.
Feijen EA; Leisenring WM; Stratton KL; Ness KK; van der Pal HJ; Caron HN; Armstrong GT; Green DM; Hudson MM; Oeffinger KC; Robison LL; Stovall M; Kremer LC; Chow EJ
J Clin Oncol; 2015 Nov; 33(32):3774-80. PubMed ID: 26304888
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of anthracycline-induced late cardiomyopathy by exercise-spiroergometry and stress-echocardiography.
Hauser M; Gibson BS; Wilson N
Eur J Pediatr; 2001 Oct; 160(10):607-10. PubMed ID: 11686505
[TBL] [Abstract][Full Text] [Related]
6. Anthracycline dose in childhood acute lymphoblastic leukemia: issues of early survival versus late cardiotoxicity.
Sorensen K; Levitt G; Bull C; Chessells J; Sullivan I
J Clin Oncol; 1997 Jan; 15(1):61-8. PubMed ID: 8996125
[TBL] [Abstract][Full Text] [Related]
7. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia.
Lipshultz SE; Lipsitz SR; Sallan SE; Dalton VM; Mone SM; Gelber RD; Colan SD
J Clin Oncol; 2005 Apr; 23(12):2629-36. PubMed ID: 15837978
[TBL] [Abstract][Full Text] [Related]
8. Does anthracycline administration by infusion in children affect late cardiotoxicity?
Levitt GA; Dorup I; Sorensen K; Sullivan I
Br J Haematol; 2004 Feb; 124(4):463-8. PubMed ID: 14984495
[TBL] [Abstract][Full Text] [Related]
9. Late cardiotoxicity of anthracyclines in children with acute leukemia.
Zalewska-Szewczyk B; Lipiec J; Bodalski J
Klin Padiatr; 1999; 211(4):356-9. PubMed ID: 10472576
[TBL] [Abstract][Full Text] [Related]
10. Lung function and exercise capacity in survivors of childhood leukaemia.
Jenney ME; Faragher EB; Jones PH; Woodcock A
Med Pediatr Oncol; 1995 Apr; 24(4):222-30. PubMed ID: 7700166
[TBL] [Abstract][Full Text] [Related]
11. [Noninvasive evaluation of chronic cumulative and acute cardiotoxicity induced by anthracycline in children with acute leukemia. Assessment of mainly left ventricular contractile state by M mode echocardiography].
Nakada S; Ogawa S; Hirayama T
Nihon Ika Daigaku Zasshi; 1994 Jun; 61(3):209-19. PubMed ID: 8045995
[TBL] [Abstract][Full Text] [Related]
12. Detection of early anthracycline-induced cardiotoxicity in childhood cancer with dobutamine stress echocardiography.
Lenk MK; Zeybek C; Okutan V; Ozcan O; Gökçay E
Turk J Pediatr; 1998; 40(3):373-83. PubMed ID: 9763901
[TBL] [Abstract][Full Text] [Related]
13. Late cardiac damage of anthracycline therapy for acute lymphoblastic leukemia in childhood.
Prestor VV; Rakovec P; Kozelj M; Jereb B
Pediatr Hematol Oncol; 2000; 17(7):527-40. PubMed ID: 11033728
[TBL] [Abstract][Full Text] [Related]
14. Subclinical anthracycline-induced cardiotoxicity in long-term follow-up of asymptomatic childhood cancer survivors: Assessment by speckle tracking echocardiography.
Çetin S; Babaoğlu K; Başar EZ; Deveci M; Çorapçıoğlu F
Echocardiography; 2018 Feb; 35(2):234-240. PubMed ID: 29106752
[TBL] [Abstract][Full Text] [Related]
15. Daunorubicin-induced cell kill with 1-hour versus 24-hour infusions: a randomized comparison in children with newly diagnosed acute lymphoblastic leukemia.
Escherich G; Göbel U; Jorch N; Spaar HJ; Janka-Schaub GE
Klin Padiatr; 2007; 219(3):134-8. PubMed ID: 17525906
[TBL] [Abstract][Full Text] [Related]
16. Low anthracyclines doses-induced cardiotoxicity in acute lymphoblastic leukemia long-term female survivors.
Amigoni M; Giannattasio C; Fraschini D; Galbiati M; Capra AC; Madotto F; Cesana F; Jankovic M; Masera G; Mancia G
Pediatr Blood Cancer; 2010 Dec; 55(7):1343-7. PubMed ID: 20589666
[TBL] [Abstract][Full Text] [Related]
17. Impaired mitochondrial function is abrogated by dexrazoxane in doxorubicin-treated childhood acute lymphoblastic leukemia survivors.
Lipshultz SE; Anderson LM; Miller TL; Gerschenson M; Stevenson KE; Neuberg DS; Franco VI; LiButti DE; Silverman LB; Vrooman LM; Sallan SE;
Cancer; 2016 Mar; 122(6):946-53. PubMed ID: 26762648
[TBL] [Abstract][Full Text] [Related]
18. Functional myocardial impairment in children treated with anthracyclines for cancer.
Yeung ST; Yoong C; Spink J; Galbraith A; Smith PJ
Lancet; 1991 Apr; 337(8745):816-8. PubMed ID: 1672914
[TBL] [Abstract][Full Text] [Related]
19. Doxorubicin treatments induce significant changes on the cardiac autonomic nervous system in childhood acute lymphoblastic leukemia long-term survivors.
Caru M; Corbin D; Périé D; Lemay V; Delfrate J; Drouin S; Bertout L; Krajinovic M; Laverdière C; Andelfinger G; Sinnett D; Curnier D
Clin Res Cardiol; 2019 Sep; 108(9):1000-1008. PubMed ID: 30778669
[TBL] [Abstract][Full Text] [Related]
20. [Long-term study of anthracycline-induced cardiomyopathy in children and adolescents].
Koch H; Schmitz L; Brockmeier K; Hartmann R; Bein G; Henze G
Klin Padiatr; 1991; 203(4):262-7. PubMed ID: 1942932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
